TY - JOUR
T1 - Protein detection in blood via a chimeric aptafluorescence assay
T2 - Toward point-of-care diagnostic devices
AU - Montero-Oleas, Andrea
AU - Costa-Vera, Cesar
AU - Samaniego Onofre, Elizabeth
AU - Mendez, Miguel Angel
N1 - Publisher Copyright:
© 2018 SPIE
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Paper-based analytics allows building portable and disposable devices for point-of-care (POC) diagnosis. Conventional methods for quantifying proteins exhibit substantial disadvantages related to costs and difficulty of the technique when used in settings where fast and cost-effective assays are needed. We report the successful application of a simple, rapid, easy to use, and label-free aptasensor strategy based on the selective fluorescence of the NMM IX dye. For the probe design, the three-dimensional (3-D) structures of the DNA components were carefully analyzed using software for the 3-D visualization of crystallographic structures. The chimeric aptafluorescence molecule consists of two modules, a detection aptamer and a transduction sequence that induces the specific fluorescence of NMM IX. In the presence of thrombin, a fluorescent spot visible to the naked eye can be observed. The fluorescent response is directly proportional to protein concentration and can be easily quantified colorimetrically using a low-cost microscopy system. The recognition probe design might be adaptable to other relevant biological analytes by changing the sequence of the aptamer. This proof of principle represents a contribution to the development of useful, cheap, reliable, and simple protein quantification assays for POC testing.
AB - Paper-based analytics allows building portable and disposable devices for point-of-care (POC) diagnosis. Conventional methods for quantifying proteins exhibit substantial disadvantages related to costs and difficulty of the technique when used in settings where fast and cost-effective assays are needed. We report the successful application of a simple, rapid, easy to use, and label-free aptasensor strategy based on the selective fluorescence of the NMM IX dye. For the probe design, the three-dimensional (3-D) structures of the DNA components were carefully analyzed using software for the 3-D visualization of crystallographic structures. The chimeric aptafluorescence molecule consists of two modules, a detection aptamer and a transduction sequence that induces the specific fluorescence of NMM IX. In the presence of thrombin, a fluorescent spot visible to the naked eye can be observed. The fluorescent response is directly proportional to protein concentration and can be easily quantified colorimetrically using a low-cost microscopy system. The recognition probe design might be adaptable to other relevant biological analytes by changing the sequence of the aptamer. This proof of principle represents a contribution to the development of useful, cheap, reliable, and simple protein quantification assays for POC testing.
KW - Aptasensor
KW - Chimeric aptafluorescence assay.
KW - In silico design
KW - Label-free
KW - N-methyl-mesoporphyrin IX
KW - Point-of-care device
UR - http://www.scopus.com/inward/record.url?scp=85054011355&partnerID=8YFLogxK
U2 - 10.1117/1.JBO.23.9.097003
DO - 10.1117/1.JBO.23.9.097003
M3 - Artículo
C2 - 30255671
AN - SCOPUS:85054011355
SN - 1083-3668
VL - 23
JO - Journal of Biomedical Optics
JF - Journal of Biomedical Optics
IS - 9
M1 - 097003
ER -